Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
about
Estimating point and interval frequency of antigen-specific CD4+ T cells based on short in vitro expansion and improved poisson distribution analysisNew design of MHC class II tetramers to accommodate fundamental principles of antigen presentationHigh throughput T epitope mapping and vaccine developmentMonitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers.In situ detection of autoreactive CD4 T cells in brain and heart using major histocompatibility complex class II dextramers.MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.The curation guidelines of the immune epitope database and analysis resourceAnalysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.Detection of Foreign Antigen-specific CD4(+)Foxp3(+) Regulatory T Cells by MHC Class II Tetramer and Intracellular CD154 Staining.Direct staining with major histocompatibility complex class II dextramers permits detection of antigen-specific, autoreactive CD4 T cells in situRegulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection.Basic principles of tumor-associated regulatory T cell biology.A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides.Measuring antigen-specific immune responses, 2008 update.
P2860
Q31082473-9F4D3B91-6203-48B0-8986-3FE797283374Q33348203-0BCF9992-182B-4845-B7D4-2F20F19F5DE1Q33628719-8B3A80C3-D174-4958-B501-F95AF4F1B65CQ33841896-8A96CD67-54F3-4AC3-AD40-BD42A5554DCDQ35229338-A9BF44FE-748B-44DC-B3BC-8F480B90FA19Q36579158-A088DCAA-B0D2-4FA6-882F-4F32F6A143B6Q37002084-60775893-B6A3-42CE-95F6-8748BA3C3A35Q37054621-1EB1712C-757E-4647-B44A-CB07B5D47036Q37420224-F5E48F28-EE07-4743-988C-71AAB38EA3A3Q37521270-55674226-6B8A-4CA7-A0DE-B7AD9C8066E6Q37700859-D2C3402C-DCAE-4D19-A14A-302D919350D3Q38045603-80BD5B93-A728-4338-B997-039D904DB3B4Q39207628-D509CD0C-3401-4D9E-B478-62A53C3E2C17Q39725034-232C3123-C559-4910-B2B4-51028445B86CQ42640948-181E72C3-13A4-4B2E-A7CD-CCD75C0B32BB
P2860
Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Use of MHC class II tetramers ...... onses: problems and solutions.
@en
Use of MHC class II tetramers ...... onses: problems and solutions.
@nl
type
label
Use of MHC class II tetramers ...... onses: problems and solutions.
@en
Use of MHC class II tetramers ...... onses: problems and solutions.
@nl
prefLabel
Use of MHC class II tetramers ...... onses: problems and solutions.
@en
Use of MHC class II tetramers ...... onses: problems and solutions.
@nl
P2093
P2860
P356
P1433
P1476
Use of MHC class II tetramers ...... onses: problems and solutions.
@en
P2093
Monica Moro
Sara Del Mare
Virginia Cecconi
P2860
P304
P356
10.1002/CYTO.A.20603
P577
2008-11-01T00:00:00Z